Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling
Adrian Wullweber(Evangelisches Krankenhaus Düsseldorf), Markus Eckstein(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bernd Wullich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sven Wach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Fabienne Lange, PL Strissel, Johannes Breyer(University of Regensburg), A. Hartmann, M. Burger, Veronika Weyerer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Simone Bertz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Danijel Sikic(Friedrich-Alexander-Universität Erlangen-Nürnberg), Reiner Strick(Friedrich-Alexander-Universität Erlangen-Nürnberg), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Helge Täubert(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 9
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
|Cell|2017|521
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Dietary bioflavonoids induce cleavage in the <i>MLL</i> gene and may contribute to infant leukemia
|Proceedings of the National Academy of Sciences|2000|390
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386